TSS
NVOS

Two Sigma Securities’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Two Sigma Securities’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,397
Closed -$10.1K – 3795
2023
Q3 		$10.1K Sell
3,397
-3,051
-47% -$5.57K ﹤0.01% 2693
2023
Q2 		$9.55K Sell
6,448
-738
-10% -$1.01K ﹤0.01% 2604
2023
Q1 		$8.82K Buy
+7,186
New +$9.55K ﹤0.01% 2473
2022
Q1 		– Sell
-1,318
Closed -$18K – 2643
2021
Q4 		$18K Buy
+1,318
New +$20.8K ﹤0.01% 1428

Other funds holding NVOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's NVOS Position: Q4 2023 in Review

Two Sigma Securities sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2023, closing a stake of 3,397 shares — an estimated $10.1K sold.

Two Sigma Securities first reported a position in NVOS in Q4 2021 and held it in 4 quarters. The position peaked at $18K in Q4 2021. 16 funds tracked by Wall St. Rank hold NVOS as of Q4 2023.

  • Two Sigma Securities reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 3,397 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2023, an estimated $10.1K.
  • Two Sigma Securities first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Two Sigma Securities's Novo Integrated Sciences, Inc. Common Stock position peaked at $18K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.